MammoSightAI is an AI-enabled medical device from Neurocareai, Inc. (Dba Savelife.Ai), listed by FDA (510(k), K252954) with a decision date of 2026-05-04. Review panel: Radiology.
| FDA submission number | K252954 |
|---|---|
| Pathway | 510(k) |
| Company | Neurocareai, Inc. (Dba Savelife.Ai) |
| Review panel (specialty) | Radiology |
| FDA decision date | 2026-05-04 |
| Decision | Substantially Equivalent |
| Product code | QFM |
| Classification | Radiological Computer-Assisted Prioritization Software For Lesions |
| Device class | 2 |
| Regulation number | 892.2080 |
| Review time (calendar days) | 230 |
| Applicant country | US |
Official FDA database record · FDA AI-enabled device list
All Radiology AI devices · Full device index
Data from FDA's AI-enabled device list and openFDA. Informational only; verify against the FDA record.